Abstract p16 immunohistochemistry (IHC) is commonly used as a surrogate marker for human papillomavirus (HPV) detection in squamous cell carcinomas of the head and neck (SCCHN). However, the HPV status of tumors not staining strongly for p16 is difficult to interpret and may require the use of PCR, not available in all laboratories, as a final arbiter. We aim to determine if staining pattern in equivocal p16 staining and correlation to the percentage of positively stained tumor cells is predictive of HPV status. A retrospective review was performed on all SCCHN that underwent p16 IHC and PCR in our institution from 2007 to 2010. Descriptors of staining pattern in the original IHC report were retrieved. All available IHC slides were reviewed and reclassified using consensus staining pattern descriptors. Original and reclassified descriptors were compared to the final PCR HPV status for statistical significance using the v 2 test. An estimate of the percentage of tumor cells that showed any form of staining was performed. Thirty-two SCCHN cases that underwent PCR HPV testing had equivocal p16 IHC results. Twentysix cases available for review were reclassified into four staining patterns. Comparing age, sex, tumor site and diagnosis to HPV PCR status showed no statistically significant findings. However, comparing original descriptors to HPV status was statistically significant with isolated staining associated with negative HPV status (p = 0.0002). Analysis using reclassified descriptors showed strong association of membranous/cytoplasmic staining of isolated cells with negative HPV status and faint, diffuse nuclear and cytoplasmic staining with positive HPV status (p = 0.00006). HPV-negative cases with the former pattern had no more than 30 % positively-stained tumor cells and HPV-positive cases with the latter pattern had 50-90 % positively-stained cells. Our results suggest that pattern of staining in p16 IHC is associated with HPV status. For instance, a diffuse nuclear and cytoplasmic staining pattern, regardless of intensity, is associated with HPV positivity. The HPV-positive cases determined by staining pattern were also associated with a higher percentage of stained tumor cells.
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Introduction
Human papillomavirus (HPV), most frequently HPV type 16, has been identified in 40-80 % of oropharyngeal cancers in the United States [1] . HPV-positive squamous cell carcinomas of the head and neck (HNSCC) most commonly arise in the lingual and palatine tonsils [2] . Patients are more likely to be non-smokers and non-drinkers than their HPV-negative counterparts, although HPV-positive HNSCC may also be seen in heavy smokers and drinkers, and are younger than patients with tobacco-associated lesions. Oral sex and increased numbers of sexual partners are also considered major risk factors [1] . The presence of HPV in HNSCC has been shown to be an important prognostic finding as HPV-positive tumors have better clinical outcome than HPV-negative ones [3] [4] [5] [6] . Clinical trials, such as the RTOG 1016 trial [7] , are underway to determine whether patients with HPV-positive HNSCC may benefit from different treatment regimens compared to current practices.
Histologically, HPV-positive HNSCC is commonly characterized by a non-keratinizing or, less commonly, basaloid morphologic pattern, although morphology alone cannot accurately determine the presence of HPV in individual patients [8] . Various detection methods ranging from immunohistochemistry (IHC) to molecular techniques have been used to determine the HPV status of HNSCC. p16 IHC has been regarded by some authors as a costeffective and practical surrogate marker of HPV status in HNSCC [9] [10] [11] [12] [13] . However, there is no clear guidance on the definition of a ''positive'' p16 IHC result. Some studies have used a cutoff of 70 % of tumor cells expressing diffuse, nuclear and cytoplasmic p16 [12, 14] (Fig. 1) , while others have developed a 3-tier scoring system akin to Her2/ neu IHC in the breast [13, 15] . Another recent study examined a combination of staining extent (i.e. quartiles of percentage of tumor cells stained) and confluency of staining (i.e. back-to-back cell staining) in determining HPV status in tumors with partial p16 staining results [16] . While there is no argument that a case with all tumor cells showing strong, diffuse staining qualifies as a positive result and one where the tumor cells show no staining is undoubtedly negative, the interpretation of results that do not fall into these clear-cut binary states often require alternative techniques such as in situ hybridization (ISH) or PCR to determine their HPV status. In our institution, all cases of oropharyngeal squamous cell carcinoma (SCC) and all HNSCC with a basaloid or papillary histology are reflexively tested using p16 IHC. In addition, HNSCC cases with a clinical history of cystic nodal metastases, unusual clinical behavior, young age or those with no known risk factors for HNSCC (e.g. smoking, alcohol, family history) are also tested by IHC regardless of site or histologic type. Thereafter, only cases demonstrating equivocal p16 IHC staining are referred for PCR since we assume that a positive/negative p16 result closely correlates with HPV status. The main aims of this study are to report our experience with HNSCC showing equivocal p16 staining and to determine if p16 staining patterns alone could predict HPV status thereby reducing the need for additional HPV testing.
Materials and Methods
A retrospective review was performed on all pathology reports of HNSCC that underwent both p16 IHC and HPV-PCR in our institution between 2007 and 2010. Each report with p16 IHC results worded other than as a simple ''positive'' or ''negative'' was compared to the final PCR report. Keywords describing the equivocal staining pattern in the original p16 IHC report (e.g. focal, weak, inconclusive or equivocal staining) were retrieved and designated ''original descriptors''. All available original p16 IHC slides and corresponding routine hematoxylin and eosin slides were subsequently reviewed and cases grouped into similar staining patterns. The following consensus descriptors of staining pattern were agreed upon by two authors (ZWC, BPO) to be assigned to these categories: ''(A) isolated cells with membranous/cytoplasmic staining at periphery of nests'' (Fig. 2) , ''(B) faint, diffuse nuclear and cytoplasmic staining'' (Fig. 3) , ''(C) isolated, faint nuclear and cytoplasmic staining'' (Fig. 4) and ''(D) faint, diffuse staining with patches of strong staining'' (Fig. 5) . These descriptors were then designated as ''reclassified descriptors''. A semiquantitative estimate of the percentage of tumor cells that stained with p16 was also assigned to each case. A cell was assumed to be positively stained if it showed any level of staining above background levels. The original and reclassified descriptors with percentage staining in addition to age, sex, site and tumor characteristics were compared to the final PCR HPV status for statistical significance. Statistical analysis was performed using the Chi-square test. IHC for p16 was performed on 4 lm paraffin-embedded tissue sections using a 1:50 concentration of p16INK4 mouse anti-human antibody (clone G175-405; BD Pharmingen, San Diego, CA) on a BenchMark XT automated stainer (Ventana Medical Systems, Tucson, AZ). Briefly, sections underwent standard pretreatment in EDTA pH 8.0 for 1 h followed by primary antibody incubation for 32 min at 37°C and detection with the ultraView Universal DAB Detection Kit (Ventana Medical Systems). A p16-positive tumor was used for a positive control and a negative control was performed by omitting the primary antibody.
PCR testing for HPV was performed using a linear array HPV genotyping test kit (Roche Diagnostics, Laval, Canada) which uses DNA amplification by PCR and nucleic acid hybridization to detect 37 HPV DNA genotypes (types 6, 11, 16, 18, 26, 31, 33, amplification, hybridization and detection were all performed using reagents supplied with the kit and following instructions provided in the kit.
Results
A total of 392 p16 IHC tests were performed on HNSCC from 2007 to 2010 in our institution. Ninety-two cases of HNSCC were tested with the linear array HPV kit from 2007 to 2010 for various reasons in our institution. Thirtytwo (35; 8 % of all IHC cases) of these cases were tested specifically due to p16 equivocal IHC results, the remaining cases were tested for other reasons such as quality assurance, clinician request, etc. The mean age of these 32 cases was 61.3 years with a range of 43-92. The male/ female ratio was 2.2:1. The majority of specimens (17 cases; 53 %) were oropharyngeal (OP) tumors, including base of tongue, tonsil and soft palate. Twelve cases (38 %) were from non-OP sites, including larynx, soft tissues of neck, anterior tongue and buccal mucosa. Three cases (9 %) could not be definitively classified as OP or non-OP as they were labeled as tongue and palate without further specification of location. Conventional keratinizing SCC accounted for half of all diagnoses, while the remainder consisted mainly of non-keratinizing SCC (Table 1) . Thirteen of 32 (41 %) cases were determined to be HPV-positive and 19 cases (59 %) were HPV-negative following linear array testing. High-risk HPV genotypes were found in all positive cases, the most common being type 16 ( Table 1) . The original descriptors of equivocal IHC results retrieved from the pathology reports included ''isolated'', ''focal'', ''focal and weak'', ''weak/faint'' and ''equivocal'' staining patterns. When these original descriptors were compared to the final HPV status as determined by linear array, the ''isolated'' staining pattern was strongly associated with negative HPV status (v 2 = 22.1; p = 0.0002) and the ''equivocal'' descriptor associated with positive HPV status (Table 2) (Fig. 4) . This case contained 20 % positively stained tumor cells. Another single case was assigned to the ''(D) faint, diffuse staining with patches of strong staining'' category as it had features of category B cases, but also had patches of very strong p16 staining (Fig. 5) . It contained 90 % positively stained tumor cells. Both of these isolated cases were HPV-positive. Comparing these reclassified categories to final HPV status yielded even stronger statistical significance (v 2 = 22.2; p = 0.00006) with category A cases associated with negative HPV status and category B cases associated with positive HPV status ( Table 3 ). The negative HPV status of category A cases correlated with the negative HPV status of cases with the ''isolated'' descriptor in the original report.
Discussion
Our results suggest that the pattern of p16 immunohistochemical staining in HNSCC can reliably predict HPV status in cases deemed as ''equivocal'' because they do not fall into the positive/negative dichotomy according to a numerical percentage cutoff used in many studies [17] [18] [19] [20] [21] [22] .
Westra's group [10] first used an 80 % cutoff based on studies of p16 IHC in the female genital tract [23, 24] , which had used an arbitrarily-determined cutoff. At that time, even in the cervix, there was no generally accepted cutoff, with some authors using a 25 % cutoff [25] and others assigning semi-quantitative descriptors of ''positive'', ''focal'' and ''negative'' [26] . In a subsequent study, Westra's group changed their cutoff to 70 % with no apparent explanation [12] . The inconsistency of p16 IHC criteria applied within one group is reflective of the current lack of consensus throughout the literature. Other authors [13, 15] have applied tiered scoring systems based on staining intensity and percentage of positive cells, similar to that used for Her2/neu scoring in breast cancer. As in Her2/neu scoring, it has been recommended that equivocal results be reflexively referred for confirmatory HPV testing, such as by ISH [13] . The lack of consensus IHC criteria is also evident in our own institution, as reflected by the wide variety of descriptors used in the original reports to describe ''equivocal'' staining patterns. Despite the limited number of cases in our study, all cases with ''isolated'' staining, as extracted from the original report and upon review, were consistently negative for HPV by linear array. Most cases with faint but diffuse nuclear and cytoplasmic staining as reclassified on review were positive for HPV by linear array. The main difference between category A cases (all HPV-negative), and category B, C, D cases (mostly HPV-positive) appears to be the absence of nuclear staining in the former. These findings suggest that nuclear expression of p16 is not only sufficient, but necessary for determining HPV positivity in SCCHN. In addition, our results suggest that the diffuseness rather than All cases in this category represent metastases without a known primary * Some cases contained more than one type NOS: not otherwise specified; SCC: squamous cell carcinoma SCC-IS: squamous carcinoma in situ intensity of staining is also a factor in determining HPV status, with faintly but diffusely staining tumors being HPV-positive and tumors with strong but isolated p16 staining being HPV-negative. A possible explanation for the faint staining may be inadequate antigen retrieval; category B cases may have demonstrated a classic strong, diffuse positive staining pattern had they been subjected to more aggressive antigen retrieval methods. One study that defined p16 positivity as an ''intensity cut-off of C2 and diffuse (C75 %) staining distribution in either the nuclei or cytoplasm'' [15] achieved only a 52 % sensitivity and 93 % specificity when compared to PCR for high risk HPV DNA. Although it is unclear if their PCR assay included low risk HPV types, the low sensitivity suggests that applying both an intensity and distribution criteria to p16 IHC may be resulting in weak, but diffusely stained cases to be falsely classified as HPV-negative. Another study [21] that defined p16 positivity as ''slightly positive for staining'' or C10 % of cells positive found that 14 % of p16-positive cases were in fact HPV-negative when compared to PCR results. The inability of both a low and high cutoff to accurately predict HPV status, as demonstrated by these previous studies, suggests that a quantitative cutoff for positive staining cells is insufficient by itself for predicting HPV status, and supports our findings that a combination of the diffuseness of staining and nuclear/cytoplasmic distribution should be taken into account in interpreting p16 IHC results. Indeed, while most of the HPV-negative cases in our study contained B40 % positively stained tumor cells and the HPV-positive cases generally contained C70 % stained tumor cells, a few cases were more difficult to characterize based on extent of staining alone: the single HPV-positive category C case contained only 20 % stained tumor cells and one HPVpositive category B case contained only 50 % stained tumor cells. However, extent of staining alone would have been helpful in determining the HPV status in the HPVnegative category B case containing only 30 % stained tumor cells.
Further investigation is required to elucidate the reason for HPV-negative status in the category A cases with isolated, cytoplasmic p16 staining. p16 is typically upregulated in the nucleus following HPV infection, therefore nuclear staining with or without cytoplasmic staining is to be expected in an HPV-infected cell. The significance of cytoplasmic p16 staining alone is unclear, but certain authors have postulated it represents a mechanism of p16 inactivation and others have suggested an association between cytoplasmic p16 and worse prognosis in various tumors including breast cancer [27, 28] and high-grade astrocytoma [29] . Furthermore, another study [30] examining the expression of p16 in oral squamous cell carcinomas (OSCC) reported cytoplasmic-only p16 staining in 7 cases of OSCC with metastases, whereas 8 cases of OSCC without metastases showed both cytoplasmic and nuclear staining, suggesting that cytoplasmic staining was associated with worse outcome. Unfortunately, the study did not correlate the p16 status with HPV status by ancillary methods, but it is possible the cases without nuclear staining represented true HPV-negative tumors that have generally poorer outcomes than HPV-positive ones.
While p16 IHC is a highly sensitive marker for HPV infection in oropharyngeal cancer, it is not as specific as ISH or PCR-based detection of E6 oncogene expression in frozen tissue, considered by many studies to be the gold standard [12, 15] . Unlike ISH, p16 IHC is not able to differentiate between tumors with HPV DNA in the integrated or episomal form, an active area of research in both the female genital tract and HNSCC [11] . Some have shown that HPV ? HNSCC are almost exclusively HPV type 16 [31] , which is strongly associated with integration into host DNA in female gynecologic lesions [32, 33] , while others have found that HPV is almost never integrated, but induces carcinogenesis through overexpression of E6/E7 oncoproteins by episomal viral sequences [34] . Therefore, a significant advantage of ISH over IHC is its ability to gather information regarding viral integration status that may prove valuable in future studies comparing prognosis in tumors with and without integrated HPV DNA. Nevertheless, both ISH and PCR are more expensive techniques to perform than IHC and may not be accessible to all pathology laboratories. As such, we framed this study within the somewhat theoretical confines of a situation where p16 IHC is the only tool available for determination of HPV status. Nevertheless, this situation is not entirely hypothetical as ancillary techniques for HPV testing are not available in all laboratories and referring a case to an outside laboratory necessitates a delay in diagnosis. Thus, at the very least, giving a probability of the HPV status in cases with equivocal p16 IHC based on staining pattern may be useful while awaiting further confirmatory testing. Eventually, a study with a larger sample size may validate our findings and greatly reduce the need for ancillary testing of cases with so-called ''equivocal'' p16 staining patterns, which would be of significant benefit to resourceconstrained laboratories.
In summary, the pattern of staining in p16 IHC in HNSCC deemed ''equivocal'' may predict tumor HPV status. Staining pattern also correlates well with tumor extent in terms of the percentage of positively stained tumor cells, and may be helpful in determining HPV status in cases with a ''borderline'' staining extent, i.e. between 40 and 70 % stained tumor cells. We propose the following definitions of positive and negative p16 expression by IHC in HNSCC with strong likelihood of correlation to their respective HPV status: (1) positive-diffuse nuclear and cytoplasmic staining of the majority (C70 %) of tumor cells, regardless of intensity of staining (when background staining is taken into consideration), and (2) negative-complete absence of staining in all tumor cells or membranous/cytoplasmic staining of rare, isolated tumor cells (B40 % stained tumor cells). For cases that do not display either staining pattern and remain ambiguous, referral to ancillary testing methods such as PCR is recommended.
